Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Yes-associated protein 1 (YAP1) is a transcriptional coactivator and a key downstream effector of the Hippo signaling pathway. It plays a central role in regulating organ size, tissue regeneration, cell proliferation, apoptosis suppression, and tumorigenesis. YAP1 promotes the expression of genes involved in cell proliferation and suppresses apoptotic genes. In its dephosphorylated state, it translocates to the nucleus where it binds TEAD family transcription factors to drive target gene expression. When phosphorylated by upstream Hippo pathway kinases such as LATS/MST, it is sequestered in the cytoplasm or targeted for degradation.
Transcriptional coactivation via binding to TEAD family transcription factors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Yes-associated protein 1 (YAP1).